First Trust Advisors LP Procept Bio Robotics Corp Transaction History

First Trust Advisors LP

$108 Billion
Q1 2025

A detailed history of First Trust Advisors LP transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, First Trust Advisors LP holds 61,442 shares of PRCT stock, worth $3.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

61,442

Previous 110,982 44.64%

Holding current value

$3.7 Million

Previous $8.94 Million 59.95%

% of portfolio

0.0%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$56.03 - $88.57 $2.78 Million - $4.39 Million	-49,540 Reduced 44.64%	61,442 $3.58 Million
Q4 2024 Feb 13, 2025	SELL	$67.27 - $99.45 $61,552 - $90,996	-915 Reduced 0.82%	110,982 $8.94 Million
Q3 2024 Nov 13, 2024	BUY	$56.31 - $84.99 $31,533 - $47,594	560 Added 0.5%	111,897 $8.96 Million
Q2 2024 Aug 13, 2024	BUY	$45.73 - $69.19 $1.51 Million - $2.29 Million	33,051 Added 42.22%	111,337 $6.8 Million
Q1 2024 May 13, 2024	BUY	$40.38 - $50.75 $782,120 - $982,976	19,369 Added 32.88%	78,286 $3.87 Million
Q4 2023 Feb 13, 2024	BUY	$24.89 - $43.41 $233,468 - $407,185	9,380 Added 18.94%	58,917 $2.47 Million
Q3 2023 Nov 13, 2023	BUY	$30.02 - $38.81 $1.49 Million - $1.92 Million	49,537 New	49,537 $1.63 Million
Q1 2023 May 15, 2023	SELL	$26.64 - $39.74 $2.33 Million - $3.47 Million	-87,391 Reduced 53.19%	76,923 $2.18 Million
Q4 2022 Feb 09, 2023	BUY	$38.78 - $46.78 $3.42 Million - $4.12 Million	88,141 Added 115.71%	164,314 $6.83 Million
Q3 2022 Nov 14, 2022	BUY	$30.9 - $50.65 $658,973 - $1.08 Million	21,326 Added 38.88%	76,173 $3.16 Million
Q2 2022 Aug 12, 2022	BUY	$29.23 - $44.45 $1.6 Million - $2.44 Million	54,847 New	54,847 $1.79 Million

Others Institutions Holding PRCT

# of Institutions

301

Shares Held

41.9M

Call Options Held

293K

Put Options Held

141K

View Full List

About PROCEPT BioRobotics Corp

Ticker PRCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,592,300
Market Cap $2.69B
Description
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...

More about PRCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Procept Bio Robotics Corp Transaction History